Iranian researchers at a knowledge-based pharmaceutical firm have developed the nation’s first plant-based children’s dietary supplement. This innovative chewable product replaces conventional bitter pills with appealing flavored gummies designed specifically for young consumers. Furthermore, domestic manufacturing will save the national economy between three million and four million dollars annually.
Parents frequently struggle when administering traditional health products to reluctant children due to unpleasant tasting formulations. Consequently, nutrient deficiencies often threaten child development when young patients consistently refuse necessary daily vitamins. Researchers operating out of Tehran’s Pardis Technology Park solved this issue by creating palatable chewable alternatives.
Chief Executive Officer Mohammadreza Fazeli announced that his company established the primary manufacturing facility in Golestan province. Additionally, he emphasized that the formulation excludes animal gelatin and utilizes plant-derived pectin as the structural base. The research team also selected natural ingredient extracts rather than synthetic dyes to achieve vibrant colors.
The pharmaceutical company distributes two distinct products across local commercial markets for immediate consumer access. Consumers can readily purchase both a general multivitamin and a specialized vitamin D health product. Therefore, young patients who struggle with standard pill shapes can comfortably consume these tasty fruit-flavored options.
Production Manager Majid Lavasani confirmed that this launch marks the first official pharmaceutical-grade gummy made domestically. Moreover, initial retail performance demonstrates strong consumer acceptance and growing market demand across regional distribution channels. The founding design concept directly leverages children’s natural preference for chewy candy shapes and sweet tastes.
Lavasani noted that replacing harmful sugars with essential vitamins transforms treat consumption into a positive health habit. Therefore, children receive necessary daily micronutrients while enjoying an appealing daily treat during routine healthcare regimens. This manufacturing approach effectively bridges the gap between medicinal utility and pleasant everyday eating experiences.
Research and Development Manager Amin Esmaeili highlighted the strict safety standards incorporated into every batch produced. The research group completely eliminated common chemical allergens by sourcing pure natural raw ingredients throughout synthesis. Consequently, sensitive young consumers can safely digest these items without experiencing adverse chemical reactions or discomfort.
Domestic sourcing of raw materials drastically reduces national dependence on costly foreign pharmaceutical imports. Local supply chains now supply essential ingredients, fostering domestic self-reliance within the healthcare innovation industry. Looking ahead, the company plans to expand its specialized production lines to create additional wellness products.